Literature DB >> 9024241

A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.

J L Stock1, M R Warth, B T Teh, J A Coderre, J H Overdorf, G Baumann, R L Hintz, M L Hartman, B R Seizinger, C Larsson, N Aronin.   

Abstract

Acromegaly is uncommon in kindreds with multiple endocrine neoplasia type 1 (MEN1), whereas primary hyperparathyroidism (PHP) has the highest penetrance of any endocrinopathy. We report an unusual MEN1 kindred with frequent expression of pituitary tumors and a low penetrance of PHP. Four members were found to have disease: PHP in generation I, acromegaly (2 cases) in generation II, and hyperprolactinemia associated with a pituitary tumor in generation III. There was no evidence for PHP in 1 patient with acromegaly (age 60 yr), the patient with hyperprolactinemia and the pituitary tumor (age 22 yr), and 1 asymptomatic obligate carrier (age 50 yr). Screening of 26 members revealed the possible diagnosis of PHP in 1 family member in generation II and possible early acromegaly in 2 members of generation III with elevated serum concentrations of insulin-like growth factor I and insulin-like growth factor-binding protein-3 but normal patterns of pulsatile GH release. Although the predisposing genetic defect in typical MEN1 families has previously been mapped to chromosome location 11q13 without evidence of heterogeneity among the 87 families analyzed, linkage of disease in this family to the MEN1 region is unlikely based on haplotype analysis. Localization of the gene(s) responsible for disease in such atypical families may aid in the understanding of the pathogenesis of MEN1. In addition, further study of the earliest changes in patterns of pulsatile GH release in familial acromegaly may allow more insight into the pathogenesis and natural history of this disease.

Entities:  

Mesh:

Year:  1997        PMID: 9024241     DOI: 10.1210/jcem.82.2.3730

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.

Authors:  C A Stratakis; M A Tichomirowa; S Boikos; M F Azevedo; M Lodish; M Martari; S Verma; A F Daly; M Raygada; M F Keil; J Papademetriou; L Drori-Herishanu; A Horvath; K M Tsang; M Nesterova; S Franklin; J-F Vanbellinghen; V Bours; R Salvatori; A Beckers
Journal:  Clin Genet       Date:  2010-11       Impact factor: 4.438

2.  Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.

Authors:  Paraskevi Xekouki; Monalisa Azevedo; Constantine A Stratakis
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

3.  Characterization of mutations in patients with multiple endocrine neoplasia type 1.

Authors:  J H Bassett; S A Forbes; A A Pannett; S E Lloyd; P T Christie; C Wooding; B Harding; G M Besser; C R Edwards; J P Monson; J Sampson; J A Wass; M H Wheeler; R V Thakker
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 4.  The MEN1 gene and associated diseases: an update.

Authors:  T Tsukada; K Yamaguchi; T Kameya
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Isolated familial somatotropinoma.

Authors:  Beatriz Santana Soares; Lawrence A Frohman
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 6.  Familial acromegaly: case report and review of the literature.

Authors:  A Verloes; A Stevenaert; B T Teh; P Petrossians; A Beckers
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

7.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

Authors:  S Giraud; C X Zhang; O Serova-Sinilnikova; V Wautot; J Salandre; N Buisson; C Waterlot; C Bauters; N Porchet; J P Aubert; P Emy; G Cadiot; B Delemer; O Chabre; P Niccoli; F Leprat; F Duron; B Emperauger; P Cougard; P Goudet; E Sarfati; J P Riou; S Guichard; M Rodier; A Meyrier; P Caron; M C Vantyghem; M Assayag; J L Peix; M Pugeat; V Rohmer; M Vallotton; G Lenoir; P Gaudray; C Proye; B Conte-Devolx; P Chanson; Y Y Shugart; D Goldgar; A Murat; A Calender
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

Review 8.  Familial gigantism.

Authors:  Wouter W de Herder
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.